EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents

Hiroaki Kato, Sho Miyatake, Ippei Yamaoka

Journal of the ASEAN Federation of Endocrine Societies · 2025

DOI: 10.15605/jafes.040.02.06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the ASEAN Federation of Endocrine Societies, 2025. Verfasst von Hiroaki Kato und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Foods Research Institute, Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan. Hauptthemen laut MEDLINE: Enteral Nutrition, Blood Glucose, Triglycerides, Glucose. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To verify whether reducing the energy ratio of carbohydrates and increasing the ratio of fats contributes to suppressing blood glucose elevation not only under normal conditions but also under the effects of glucocorticoids. Methodology. Three test enteral nutrition (EN) solutions, differing in energy ratios and used in actual clinical settings, were given to rats: HINEX E-Gel (ST) with 20% fat and 64% carbohydrate content; HINEX E-Gel LC (LC) with 34% fat and 50% carbohydrate content; and HINEX Renute (RN) with 50% fat and 26% carbohydrate content. The time-course data of plasma glucose, triglyceride, and insulin levels after a single oral administration of the test EN solution were obtained in normal rats (Experiment 1) and in hyperglycemia model rats treated with dexamethasone (Experiment 2).

Results

In both normal and dexamethasone-induced hyperglycemic rats, plasma glucose levels were lower in the groups given RN than in the groups given ST. The differences in EN solutions did not significantly affect plasma triglyceride and insulin levels in either rat model.

Conclusion

The study suggests that an EN solution high in fat and low in carbohydrate suppresses the post-administration increase of blood glucose levels, even in a state of steroid-induced hyperglycemia with insulin resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enteral NutritionBlood GlucoseTriglyceridesGlucoseDietary FatsAnimalsRatsMaleDexamethasoneInsulinHyperglycemiaRats, WistarGlucocorticoidsRats, Sprague-Dawley

Stichwörter der Autor:innen

blood glucoseenteral nutritionplasma insulinsteroid-induced hyperglycemiasurgical stresstriglycerides

Substanzen

Blood GlucoseTriglyceridesDexamethasoneInsulinGlucoseDietary FatsGlucocorticoids

Autor:innen und Institutionen

  • Medical Foods Research Institute, Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan.

Zitieren

APA

Kato, H., Miyatake, S., & Yamaoka, I. (2025). Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents. Journal of the ASEAN Federation of Endocrine Societies. https://doi.org/10.15605/jafes.040.02.06

Vancouver

Kato H, Miyatake S, Yamaoka I. Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents. Journal of the ASEAN Federation of Endocrine Societies. 2025. doi:10.15605/jafes.040.02.06

BibTeX
@article{Kato2025,
  author = {Kato, Hiroaki and Miyatake, Sho and Yamaoka, Ippei},
  title = {Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents},
  journal = {Journal of the ASEAN Federation of Endocrine Societies},
  year = {2025},
  doi = {10.15605/jafes.040.02.06}
}
Kostenlos starten →